Benzinga's Top Upgrades, Downgrades For February 25, 2019


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Top Upgrades

  • JP Morgan upgraded Brunswick Corporation (NYSE:BC) from Neutral to Overweight. Brunswick shares rose 1.8 percent to close at $53.04 on Friday.
  • Macquarie upgraded Norwegian Cruise Line Holdings Ltd (NYSE:NCLH) from Neutral to Outperform. Norwegian Cruise shares rose 1.2 percent to $56.00 in pre-market trading.
  • H.C. Wainwright upgraded Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) from Sell to Neutral. Ironwood Pharmaceuticals shares rose 0.49 percent to close at $14.25 on Friday.
  • MKM Partners upgraded Infinera Corp. (NASDAQ:INFN) from Sell to Neutral. Infinera shares rose 3.6 percent to $5.45 in pre-market trading.
  • Stifel Nicolaus upgraded Obalon Therapeutics Inc (NASDAQ:OBLN) from Hold to Buy. Obalon Therapeutics shares fell 8.41 percent to close at $1.96 on Friday.
  • UBS upgraded AmeriGas Partners, L.P. (NYSE:APU) from Sell to Neutral. AmeriGas Partners shares rose 0.3 percent to $29.70 in pre-market trading.
  • Chardan Capital upgraded Audentes Therapeutics Inc (NASDAQ:BOLD) from Neutral to Buy. Audentes Therapeutics shares rose 15.4 percent to $30.32 in pre-market trading.
  • Stephens & Co. upgraded Matson Inc (NYSE:MATX) from Equal-Weight to Overweight. Matson shares dropped 1.58 percent to close at $34.78 on Friday.
  • Evercore ISI Group upgraded Regenxbio Inc (NASDAQ:RGNX) from In-Line to Outperform. Regenxbio shares rose 10.2 percent to $51.25 in pre-market trading.
  • Analysts at Keefe Bruyette & Woods upgraded PennyMac Mortgage Investment Trust (NYSE:PMT) from Market Perform to Outperform. PennyMac Mortgage Investment Trust shares gained 3 percent to $20.75 in pre-market trading.

 

Top Downgrades

  • Cantor Fitzgerald downgraded Spark Therapeutics Inc (NASDAQ:ONCE) from Overweight to Neutral. Spark Therapeutics shares rose 121 percent to $113.90 in pre-market trading.
  • Imperial Capital downgraded Allegion PLC (NYSE:ALLE) from Outperform to In-Line. Allegion shares rose 1.67 percent to close at $89.70 on Friday.
  • Keefe Bruyette & Woods downgraded State Street Corp (NYSE:STT) from Market Perform to Underperform. State Street shares rose 0.3 percent to close at $72.40 on Friday.
  • Canaccord Genuity downgraded Imax Corp (NYSE:IMAX) from Buy to Hold. Imax shares fell 1.6 percent to $21.38 in pre-market trading.
  • Bernstein downgraded Kraft Heinz Co (NASDAQ:KHC) from Outperform to Market Perform. Kraft Heinz shares fell 1 percent to $34.60 in pre-market trading.
  • Macquarie downgraded HSBC Holdings plc (NYSE:HSBC) from Neutral to Underperform. HSBC shares fell 0.3 percent to $40.59 in pre-market trading.
  • Bank of America downgraded Eversource Energy (NYSE:ES) from Neutral to Underperform. Eversource Energy shares fell 0.5 percent to $69.95 in pre-market trading.
  • Citigroup downgraded Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) from Buy to Neutral. Allscripts Healthcare shares fell 11.22 percent to close at $10.60 on Friday.
  • Credit Suisse downgraded CyrusOne Inc (NASDAQ:CONE) from Outperform to Neutral. CyrusOne shares fell 0.2 percent to $52.79 in pre-market trading.
  • Raymond James downgraded KB Home (NYSE:KBH) from Outperform to Market Perform. KB Home shares fell 0.8 percent to $23.67 in pre-market trading.

 

Top Initiations

  • Morgan Stanley initiated coverage on New Fortress Energy LLC (NASDAQ:NFE) with an Overweight rating. New Fortress Energy shares closed at $14.00 on Friday.
  • H.C. Wainwright initiated coverage on Pulse Biosciences Inc (NASDAQ:PLSE) with a Buy rating. Pulse Biosciences shares closed at $18.23 on Friday.
  • Analysts at Stifel Nicolaus initiated coverage on New Fortress Energy LLC (NASDAQ:NFE) with a Buy rating. The price target for Biogen is set to $27. New Fortress Energy shares closed at $14.00 on Friday.
  • Analysts at Jefferies initiated coverage on Cronos Group Inc (NASDAQ:CRON) with an Underperform rating. Cronos shares closed at $21.92 on Friday.

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: UpgradesDowngradesInitiationPre-Market OutlookAnalyst RatingsInitiationstop upgrades